Rainbow Medical’s GluSense picks up $2M for injectable glucose sensor by Amirah Al Idrus Wednesday, February 15, 2017 GluSense, which is developing a long-term glucose-monitoring implant, has received approximately $1.9 million from the newly launched JDRF T1D Fund.
